These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11980632)

  • 1. Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer.
    Sirchia SM; Ren M; Pili R; Sironi E; Somenzi G; Ghidoni R; Toma S; Nicolò G; Sacchi N
    Cancer Res; 2002 May; 62(9):2455-61. PubMed ID: 11980632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells.
    Sirchia SM; Ferguson AT; Sironi E; Subramanyan S; Orlandi R; Sukumar S; Sacchi N
    Oncogene; 2000 Mar; 19(12):1556-63. PubMed ID: 10734315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic patterns of the retinoic acid receptor beta2 promoter in retinoic acid-resistant thyroid cancer cells.
    Cras A; Darsin-Bettinger D; Balitrand N; Cassinat B; Soulié A; Toubert ME; Delva L; Chomienne C
    Oncogene; 2007 Jun; 26(27):4018-24. PubMed ID: 17213810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
    Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E
    Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of retinoic acid receptor beta gene expression is linked to aberrant histone H3 acetylation in lung cancer cell lines.
    Suh YA; Lee HY; Virmani A; Wong J; Mann KK; Miller WH; Gazdar A; Kurie JM
    Cancer Res; 2002 Jul; 62(14):3945-9. PubMed ID: 12124324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel RARbeta isoform directed by a distinct promoter P3 and mediated by retinoic acid in breast cancer cells.
    Peng X; Maruo T; Cao Y; Punj V; Mehta R; Das Gupta TK; Christov K
    Cancer Res; 2004 Dec; 64(24):8911-8. PubMed ID: 15604252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of conserved CpG sites neighboring the beta retinoic acid response element may mediate retinoic acid receptor beta gene silencing in MCF-7 breast cancer cells.
    Arapshian A; Kuppumbatti YS; Mira-y-Lopez R
    Oncogene; 2000 Aug; 19(35):4066-70. PubMed ID: 10962564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperacetylation enhances the growth-inhibitory effect of all-trans retinoic acid by the restoration of retinoic acid receptor beta expression in head and neck squamous carcinoma (HNSCC) cells.
    Whang YM; Choi EJ; Seo JH; Kim JS; Yoo YD; Kim YH
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):543-55. PubMed ID: 15959780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesis.
    Petty WJ; Li N; Biddle A; Bounds R; Nitkin C; Ma Y; Dragnev KH; Freemantle SJ; Dmitrovsky E
    J Natl Cancer Inst; 2005 Nov; 97(22):1645-51. PubMed ID: 16288117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoic acid receptor beta2 is epigenetically silenced either by DNA methylation or repressive histone modifications at the promoter in cervical cancer cells.
    Zhang Z; Joh K; Yatsuki H; Zhao W; Soejima H; Higashimoto K; Noguchi M; Yokoyama M; Iwasaka T; Mukai T
    Cancer Lett; 2007 Mar; 247(2):318-27. PubMed ID: 16806674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y; Fatima N; Dufau ML
    Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of chromosome 3p deletion on the expression of the putative tumor suppressor RAR beta and on retinoid resistance in human squamous carcinoma cells.
    Zou CP; Youssef EM; Zou CC; Carey TE; Lotan R
    Oncogene; 2001 Oct; 20(47):6820-7. PubMed ID: 11687961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation associated with polycomb repression in retinoic acid receptor β silencing.
    Moison C; Senamaud-Beaufort C; Fourrière L; Champion C; Ceccaldi A; Lacomme S; Daunay A; Tost J; Arimondo PB; Guieysse-Peugeot AL
    FASEB J; 2013 Apr; 27(4):1468-78. PubMed ID: 23299856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer.
    Wang LG; Beklemisheva A; Liu XM; Ferrari AC; Feng J; Chiao JW
    Mol Carcinog; 2007 Jan; 46(1):24-31. PubMed ID: 16921492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing and re-expression of retinoic acid receptor beta2 in human melanoma.
    Fan J; Eastham L; Varney ME; Hall A; Adkins NL; Chetel L; Sollars VE; Georgel P; Niles RM
    Pigment Cell Melanoma Res; 2010 Jun; 23(3):419-29. PubMed ID: 20374520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
    Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo imaging of retinoic acid receptor beta2 transcriptional activation by the histone deacetylase inhibitor MS-275 in retinoid-resistant prostate cancer cells.
    Qian DZ; Ren M; Wei Y; Wang X; van de Geijn F; Rasmussen C; Nakanishi O; Sacchi N; Pili R
    Prostate; 2005 Jun; 64(1):20-8. PubMed ID: 15651062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
    Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
    Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between histone acetylation and expression of the MYO18B gene in human lung cancer cells.
    Tani M; Ito J; Nishioka M; Kohno T; Tachibana K; Shiraishi M; Takenoshita S; Yokota J
    Genes Chromosomes Cancer; 2004 Jun; 40(2):146-51. PubMed ID: 15101048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibitor Trichostatin A induces global and gene-specific DNA demethylation in human cancer cell lines.
    Ou JN; Torrisani J; Unterberger A; Provençal N; Shikimi K; Karimi M; Ekström TJ; Szyf M
    Biochem Pharmacol; 2007 May; 73(9):1297-307. PubMed ID: 17276411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.